The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Dupont Jakob | Director | Grant(A) | 46K | — | $0 |
| Aug 12, 2026 | Civik Thomas | Interim CEO, Director | Grant(A) | 251K | — | $0 |
| Jun 30, 2026 | Dupont Jakob | Director | Option exercise(M) | 35K | $1.60 | $56K |
| Jun 30, 2026 | Dupont Jakob | Director | Sell(S) | 35K | $3.06 | $107K |
| Jun 30, 2026 | Dupont Jakob | Director | Option exercise(M) | 35K | — | $0 |
| Mar 24, 2026 | Palani Santhosh | Director | Grant(A) | 46K | — | $0 |
| Mar 24, 2026 | Humphrey Rachel | Director | Grant(A) | 46K | — | $0 |
| Mar 24, 2026 | Cline Darren S | Director | Grant(A) | 46K | — | $0 |
| Mar 24, 2026 | Lewis-Hall Freda C | Director | Grant(A) | 46K | — | $0 |
| Mar 24, 2026 | Metzger Michael A | Director | Grant(A) | 46K | — | $0 |
| Mar 24, 2026 | Flavin John L | Director | Grant(A) | 46K | — | $0 |
| Mar 24, 2026 | Wadhane Jitendra | Prin Fin & Acct Officer | Grant(A) | 109K | — | $0 |
| Mar 24, 2026 | Wadhane Jitendra | Prin Fin & Acct Officer | Grant(A) | 263K | — | $0 |
| Mar 24, 2026 | Dupont Jakob | Director | Grant(A) | 46K | — | $0 |
| Feb 3, 2026 | Civik Thomas | Interim CEO, Director | Grant(A) | 690K | — | $0 |
| Apr 21, 2025 | Humphrey Rachel | Director | Sell(S) | 14K | $1.03 | $14K |
| Apr 17, 2025 | Humphrey Rachel | Director | Sell(S) | 200 | $0.97 | $194 |
| Apr 14, 2025 | Humphrey Rachel | Director | Sell(S) | 1K | $0.97 | $1K |
| Mar 31, 2025 | Flavin John L | Director | Grant(A) | 37K | $0.98 | $36K |
| Mar 31, 2025 | Connealy Pamela Ann | CFO & COO | Grant(A) | 414K | $0.98 | $406K |
| Mar 31, 2025 | Civik Thomas | Director | Grant(A) | 37K | $0.98 | $36K |
| Mar 31, 2025 | Palani Santhosh | Director | Grant(A) | 37K | $0.98 | $36K |
| Mar 31, 2025 | Dupont Jakob | Director | Grant(A) | 37K | $0.98 | $36K |
| Mar 31, 2025 | Cline Darren S | Director | Grant(A) | 37K | $0.98 | $36K |
| Mar 31, 2025 | Lewis-Hall Freda C | Director | Grant(A) | 37K | $0.98 | $36K |
| Mar 31, 2025 | Humphrey Rachel | Director | Grant(A) | 37K | $0.98 | $36K |
| Mar 31, 2025 | Wadhane Jitendra | SVP, Chief Accounting Officer | Grant(A) | 264K | $0.98 | $259K |
| Mar 31, 2025 | Metzger Michael A | Director | Grant(A) | 37K | $0.98 | $36K |
| Mar 31, 2025 | Sullivan Lara | President ,CEO & CMO, Director | Grant(A) | 918K | $0.98 | $900K |
| Dec 23, 2024 | Wadhane Jitendra | SVP, Chief Accounting Officer | Grant(A) | 150K | — | $0 |
| Dec 23, 2024 | Connealy Pamela Ann | CFO & COO | Grant(A) | 310K | — | $0 |
| Dec 23, 2024 | Sullivan Lara | Chief Executive Officer, Director | Grant(A) | 1.1M | — | $0 |
| Nov 26, 2024 | Connealy Pamela Ann | CFO & COO | Buy(P) | 5K | $2.00 | $11K |
| Nov 26, 2024 | Connealy Pamela Ann | CFO & COO | Buy(P) | 83K | $1.96 | $163K |
| Jun 10, 2024 | Metzger Michael A | Director | Grant(A) | 71K | — | $0 |
| Jun 7, 2024 | Palani Santhosh | Director | Grant(A) | 6K | — | $0 |
| Mar 26, 2024 | Wadhane Jitendra | SVP, Chief Accounting Officer | Grant(A) | 131K | — | $0 |
| Mar 26, 2024 | Civik Thomas | Director | Grant(A) | 44K | $3.83 | $169K |
| Mar 26, 2024 | Humphrey Rachel | Director | Grant(A) | 39K | — | $0 |
| Mar 26, 2024 | Dupont Jakob | Director | Grant(A) | 39K | — | $0 |
| Mar 26, 2024 | Lewis-Hall Freda C | Director | Grant(A) | 35K | — | $0 |
| Mar 26, 2024 | Flavin John L | Director | Grant(A) | 35K | — | $0 |
| Mar 26, 2024 | Cline Darren S | Director | Grant(A) | 35K | — | $0 |
| Mar 26, 2024 | Sullivan Lara | Chief Executive Officer, Director | Grant(A) | 1.1M | $3.83 | $4.1M |
| Mar 26, 2024 | Connealy Pamela Ann | CFO & COO | Grant(A) | 329K | — | $0 |
| Mar 12, 2024 | Palani Santhosh | Director | Grant(A) | 70K | — | $0 |
| Dec 29, 2023 | Kobayashi Ken | Chief Medical Officer | Grant(A) | 444K | — | $0 |
| Dec 29, 2023 | Kobayashi Ken | Chief Medical Officer | Grant(A) | 111K | — | $0 |
| Nov 29, 2023 | Connealy Pamela Ann | CFO and COO | Tax withholding(F) | 37K | $1.40 | $52K |
| Nov 15, 2023 | Wadhane Jitendra | Chief Accounting Officer | Grant(A) | 40K | — | $0 |
| Sep 28, 2023 | Connealy Pamela Ann | CFO and COO | Buy(P) | 8K | $1.87 | $15K |
| Sep 27, 2023 | Connealy Pamela Ann | CFO and COO | Buy(P) | 6K | $1.85 | $12K |
| Sep 27, 2023 | Wadhane Jitendra | Chief Accounting Officer | Buy(P) | 3K | $1.87 | $5K |
| Sep 25, 2023 | Connealy Pamela Ann | CFO and COO | Buy(P) | 12K | $1.67 | $20K |
| Sep 25, 2023 | Wadhane Jitendra | Chief Accounting Officer | Buy(P) | 5K | $1.77 | $9K |
| Sep 22, 2023 | Connealy Pamela Ann | CFO and COO | Buy(P) | 5K | $1.74 | $9K |
| Sep 22, 2023 | Wadhane Jitendra | Chief Accounting Officer | Buy(P) | 3K | $1.74 | $4K |
| Sep 22, 2023 | Dupont Jakob | Director | Grant(A) | 392K | — | $0 |
| Sep 18, 2023 | Sullivan Lara | President and CEO, Director | Sell(S) | 9K | $2.10 | $18K |
| Sep 14, 2023 | Sullivan Lara | President and CEO, Director | Sell(S) | 100 | $2.25 | $225 |
| Sep 13, 2023 | Sullivan Lara | President and CEO, Director | Sell(S) | 3K | $2.27 | $7K |
| Sep 13, 2023 | Sullivan Lara | President and CEO, Director | Tax withholding(F) | 185K | $2.13 | $394K |
| Sep 12, 2023 | Sullivan Lara | President and CEO, Director | Sell(S) | 5K | $2.25 | $11K |
| Sep 11, 2023 | Sullivan Lara | President and CEO, Director | Sell(S) | 20K | $2.27 | $45K |
| Sep 7, 2023 | Sullivan Lara | President and CEO, Director | Grant(A) | 469K | — | $0 |
| Sep 7, 2023 | Wadhane Jitendra | Chief Accounting Officer | Grant(A) | 94K | — | $0 |
| Sep 7, 2023 | Connealy Pamela Ann | CFO and COO | Grant(A) | 188K | — | $0 |
| Aug 23, 2023 | Dupont Jakob | Director | Grant(A) | 6K | — | — |
| Aug 23, 2023 | Dupont Jakob | Director | Grant(A) | 4K | — | — |
| Aug 23, 2023 | Dupont Jakob | Director | Grant(A) | 17K | — | — |
| Mar 24, 2023 | Humphrey Rachel | Director | Grant(A) | 58K | — | $0 |
| Mar 24, 2023 | Civik Thomas | Director | Grant(A) | 139K | — | $0 |
| Mar 24, 2023 | Cline Darren S | Director | Grant(A) | 139K | — | $0 |
| Mar 24, 2023 | Flavin John L | Director | Grant(A) | 139K | — | $0 |
| Mar 24, 2023 | Lewis-Hall Freda C | Director | Grant(A) | 139K | — | $0 |
| Mar 24, 2023 | Wadhane Jitendra | Chief Accounting Officer | Grant(A) | 29K | — | $0 |
| Mar 24, 2023 | Wadhane Jitendra | Chief Accounting Officer | Grant(A) | 45K | — | $0 |
| Mar 24, 2023 | Wadhane Jitendra | Chief Accounting Officer | Disposed to issuer(D) | 157K | — | — |
| Mar 24, 2023 | Wadhane Jitendra | Chief Accounting Officer | Grant(A) | 157K | — | — |
| Mar 24, 2023 | Feingold Jay | Chief Medical Officer | Grant(A) | 210K | — | $0 |
| Mar 24, 2023 | Feingold Jay | Chief Medical Officer | Grant(A) | 18K | — | — |
| Mar 24, 2023 | Feingold Jay | Chief Medical Officer | Grant(A) | 157K | — | — |
| Mar 24, 2023 | Feingold Jay | Chief Medical Officer | Disposed to issuer(D) | 18K | — | — |
| Mar 24, 2023 | Feingold Jay | Chief Medical Officer | Disposed to issuer(D) | 157K | — | — |
| Mar 24, 2023 | Yanchik Connealy Pamela | CFO and COO | Grant(A) | 210K | — | $0 |
| Mar 24, 2023 | Yanchik Connealy Pamela | CFO and COO | Grant(A) | 10K | — | — |
| Mar 24, 2023 | Yanchik Connealy Pamela | CFO and COO | Grant(A) | 322K | — | — |
| Mar 24, 2023 | Yanchik Connealy Pamela | CFO and COO | Disposed to issuer(D) | 322K | — | — |
| Mar 24, 2023 | Yanchik Connealy Pamela | CFO and COO | Disposed to issuer(D) | 10K | — | — |
| Mar 24, 2023 | Sullivan Lara | President and CEO, Director | Grant(A) | 703K | — | $0 |
| Mar 24, 2023 | Sullivan Lara | President and CEO, Director | Disposed to issuer(D) | 990K | — | — |
| Mar 24, 2023 | Sullivan Lara | President and CEO, Director | Disposed to issuer(D) | 62K | — | — |
| Mar 24, 2023 | Sullivan Lara | President and CEO, Director | Grant(A) | 990K | — | — |
| Mar 24, 2023 | Sullivan Lara | President and CEO, Director | Grant(A) | 62K | — | — |
| Mar 17, 2023 | Pfizer Inc | 10% Owner | Buy(P) | 1.8M | $2.76 | $5.0M |
| Jan 3, 2023 | Yanchik Connealy Pamela | Chief Financial Officer | Grant(A) | 43K | — | $0 |
| Jan 3, 2023 | Feingold Jay | Chief Medical Officer | Grant(A) | 54K | — | $0 |
| Jan 3, 2023 | Sullivan Lara | Chief Executive Officer, Director | Grant(A) | 96K | — | $0 |
| Aug 11, 2022 | Humphrey Rachel | Director | Grant(A) | 236K | — | $0 |
| Apr 21, 2022 | Chin Mark | Insider | Sell(S) | 1.7M | $3.05 | $5.3M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-08-28. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for PYXS